Some women report feeling unusual itchiness during the menopause transition, and according to the The North American Menopause Society, it can strike the face, back, chest, genital areapretty much anywhere
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
Chimia (Aarau) 67, 333336
Many users combine approaches: professional treatments for major wrinkle correction with copper peptide protocols for maintenance and ongoing improvement between treatments
Its documented interactions at the cellular level have made it a focal point for labs investigating tissue remodeling, antioxidant activity, and gene expression regulation